{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:42:53Z","timestamp":1793497373641,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.semarthrit.2025.152642","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:01:40Z","timestamp":1738224100000},"page":"152642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Renal outcomes and survival in amyloidosis associated with familial Mediterranean fever: A longitudinal study"],"prefix":"10.1016","volume":"71","author":[{"given":"David J","family":"Ozeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Bar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar","family":"Somech Safran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Druyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Lesya","family":"Kukuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Giat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1970-5364","authenticated-orcid":false,"given":"Avi","family":"Livneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.semarthrit.2025.152642_bib0001","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial Mediterranean Fever in the world","volume":"61","author":"Ben-Chetrit","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152642_bib0002","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.3390\/ijms24119584","article-title":"An update on familial Mediterranean fever","volume":"24","author":"Lancieri","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152642_bib0003","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/rheumatology\/keaa772","article-title":"Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever","volume":"60","author":"Kukuy","year":"2021","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152642_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","article-title":"Familial Mediterranean fever. A survey of 470 cases and review of the literature","volume":"43","author":"Sohar","year":"1967","journal-title":"Am J Med"},{"issue":"16","key":"10.1016\/j.semarthrit.2025.152642_bib0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med"},{"issue":"9103","key":"10.1016\/j.semarthrit.2025.152642_bib0006","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","article-title":"Familial Mediterranean fever","volume":"351","author":"Ben-Chetrit","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152642_bib0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000235892","article-title":"Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia","volume":"18","author":"Sevoyan","year":"2009","journal-title":"Med Princ Pract"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152642_bib0008","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial Mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"10.1016\/j.semarthrit.2025.152642_bib0009","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152642_bib0010","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/art.1780371215","article-title":"Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome","volume":"37","author":"Livneh","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152642_bib0011","first-page":"S63","article-title":"Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome","volume":"19","author":"Cakar","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152642_bib0012","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00467-003-1129-x","article-title":"Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever","volume":"18","author":"Oner","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152642_bib0013","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/ndt\/gfr528","article-title":"Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure","volume":"27","author":"Stankovic Stojanovic","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152642_bib0014","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1093\/rheumatology\/keaa211","article-title":"Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever","volume":"59","author":"Ugurlu","year":"2020","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152642_bib0015","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever","volume":"40","author":"Livneh","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152642_bib0016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/oxfordjournals.aje.a113439","article-title":"On the need for the rare disease assumption in case-control studies","volume":"116","author":"Greenland","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152642_bib0017","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<216::AID-AJMG20>3.0.CO;2-R","article-title":"Clinical differences between North African and Iraqi Jews with familial Mediterranean fever","volume":"75","author":"Pras","year":"1998","journal-title":"Am J Med Genet"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152642_bib0018","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3899\/jrheum.131135","article-title":"The kidney in familial Mediterranean fever","volume":"40","author":"Peleg","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152642_bib0019","doi-asserted-by":"crossref","unstructured":"Inker L.A., Eneanya N.D., Coresh J., Tighiouart H., Wang D., Sang Y., Crews D.C., Doria A., Estrella M.M., Froissart M., Grams M.E., Greene T., Grubb A., Gudnason V., Guti\u00e9rrez O.M., Kalil R., Karger A.B., Mauer M., Navis G., Nelson R.G., Poggio E.D., Rodby R., Rossing P., Rule A.D., Selvin E., Seegmiller J.C., Shlipak M.G., Torres V.E., Yang W., Ballew S.H., Couture S.J., Powe N.R., Levey A.S.; Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and cystatin c-based equations to estimate GFR without race. N Engl J Med. 2021 Nov 4;385(19):1737\u201349. doi: 10.1056\/NEJMoa2102953. Epub 2021 Sep 23. PMID: 34554658; PMCID: PMC8822996.","DOI":"10.1056\/NEJMoa2102953"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152642_bib0020","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152642_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5152\/eurjrheum.2014.006","article-title":"Familial Mediterranean fever: an updated review","volume":"1","author":"Sar\u0131","year":"2014","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152642_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40348-016-0058-2","article-title":"The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever","volume":"3","author":"Sozeri","year":"2016","journal-title":"Mol Cell Pediatr"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152642_bib0023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/14397595.2018.1457469","article-title":"Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis","volume":"29","author":"Varan","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152642_bib0024","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/ard-2023-225114","article-title":"bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease","volume":"83","author":"Kvacskay","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152642_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2018.08.013","article-title":"Familial Mediterranean fever (FMF) phenotype in patients homozygous to the MEFV M694V mutation","volume":"62","author":"Grossman","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152642_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2012.07.025","article-title":"Incomplete response to colchicine in M694V homozygote FMF patients","volume":"12","author":"Lidar","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152642_bib0027","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5152\/eurjrheum.2020.19136","article-title":"Comparison of clinical features in FMF patients according to severity scores: an analysis with the ISSF scoring system","volume":"7","author":"Ya\u015far Bilge","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152642_bib0028","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/annrheumdis-2015-208671","article-title":"Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)","volume":"75","author":"Demirkaya","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152642_bib0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semarthrit.2005.02.002","article-title":"Evaluation of disease severity in familial Mediterranean fever","volume":"35","author":"Mor","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152642_bib0030","first-page":"308","article-title":"Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation","volume":"30","author":"Gershoni-Baruch","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152642_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129908993281","article-title":"MEFV Mutation analysis in patients suffering from amyloidosis in Familial Mediterranean Fever","volume":"6","author":"Livneh","year":"1999","journal-title":"Amyloid"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152642_bib0032","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00296-014-3205-x","article-title":"Predictors of AA amyloidosis in familial Mediterranean fever","volume":"35","author":"Mukhin","year":"2015","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152642_bib0033","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/ket400","article-title":"Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study","volume":"53","author":"Kasifoglu","year":"2014","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152642_bib0034","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gene.2011.10.012","article-title":"Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients","volume":"492","author":"Akpolat","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.semarthrit.2025.152642_bib0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archinte.1961.03620040065007","article-title":"Amyloidosis in familial Mediterranean fever. An independent genetically determined character","volume":"107","author":"HELLER","year":"1961","journal-title":"Arch Intern Med"},{"issue":"23","key":"10.1016\/j.semarthrit.2025.152642_bib0036","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152642_bib0037","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.rbr.2016.12.002","article-title":"Clinical outcomes and survival in AA amyloidosis patients","volume":"57","author":"Ayar","year":"2017","journal-title":"Rev Bras Reumatol Engl editor"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152642_bib0038","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343398","article-title":"Renal involvement in AA amyloidosis: clinical outcomes and survival","volume":"37","author":"Yilmaz","year":"2013","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152642_bib0039","first-page":"644","article-title":"Outcome of 121 patients with renal amyloid A amyloidosis","volume":"19","author":"Ahbap","year":"2014","journal-title":"J Res Med Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152642_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rheumatology\/kead465","article-title":"Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey","volume":"63","author":"Bektas","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152642_bib0041","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ndt\/gfm684","article-title":"Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome","volume":"23","author":"Bergesio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2025.152642_bib0042","first-page":"343","article-title":"Clinical outcome and survival of secondary (AA) amyloidosis","volume":"21","author":"Tanaka","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152642_bib0043","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1742-1241.2002.tb11272.x","article-title":"Clinical and biochemical outcome of renal amyloidosis","volume":"56","author":"Odabas","year":"2002","journal-title":"Int J Clin Pract"},{"issue":"9275","key":"10.1016\/j.semarthrit.2025.152642_bib0044","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152642_bib0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13506129.2017.1350158","article-title":"Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis","volume":"24","author":"Kendi Celebi","year":"2017","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152642_bib0046","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s11255-022-03163-y","article-title":"Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis","volume":"54","author":"Ozdemir","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152642_bib0047","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/art.10964","article-title":"Amyloid-enhancing factor mediates amyloid formation on fibroblasts via a nidus\/template mechanism","volume":"48","author":"Magy","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152642_bib0048","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/art.22507","article-title":"International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever","volume":"56","author":"Touitou","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:52:16Z","timestamp":1741099936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"alternative-id":["S0049017225000137"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152642","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal outcomes and survival in amyloidosis associated with familial Mediterranean fever: A longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152642"}}